Skip to main content
Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS · Delayed Price · Currency is USD
0.0370
+0.0370 (0.00%)
Apr 25, 2025, 4:00 PM EDT

PLSH Revenue

Panacea Life Sciences Holdings had revenue of $1.06M in the quarter ending March 31, 2024, with 55.94% growth. This brings the company's revenue in the last twelve months to $2.76M, up 50.38% year-over-year. In the year 2023, Panacea Life Sciences Holdings had annual revenue of $2.38M with 46.59% growth.

Revenue (ttm)
2.76M
Revenue Growth
+50.38%
P/S Ratio
0.28
Revenue / Employee
69.10K
Employees
40
Market Cap
785.28K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.38M757.98K46.59%
Dec 31, 20221.63M-432.65K-21.01%
Dec 31, 20212.06M-6.96M-77.16%
Dec 31, 20209.02M6.82M310.19%
Dec 31, 20192.20M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
Veradigm 588.02M
Glass House Brands 200.90M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Silence Therapeutics 43.26M
Revenue Rankings

Panacea Life Sciences Holdings News

More News